LifeStance Health (LFST) Equity Ratio (2020 - 2026)

LifeStance Health has disclosed Equity Ratio across 7 years of filings, most recently posting 0.69 for Q1 2026.

• In Q1 2026, Equity Ratio fell 0.55% year-over-year to 0.69; the TTM figure through Mar 2026 stood at 0.69 (down 0.55% YoY), while the FY2025 annual figure was 0.69, up 1.08% from the prior year.
• Equity Ratio held at 0.69 in Q1 2026, from 0.69 in the prior quarter.
• Over the last five years, Equity Ratio for LFST reached as high as 0.79 in Q1 2022 and fell as low as 0.67 in Q3 2023.
• The 5-year median for Equity Ratio is 0.69 (2023), against an average of 0.7.
• Annual changes were most pronounced in 2023 — Equity Ratio dropped 13.53% — and 2025, when it gained 2.05%.
• A 5-year view of Equity Ratio shows it stood at 0.7 in 2022, then slipped by 3.06% to 0.68 in 2023, then rose by 0.82% to 0.68 in 2024, then increased by 1.08% to 0.69 in 2025, then retreated by 0.24% to 0.69 in 2026.
• According to Business Quant data, Equity Ratio over the past three periods registered 0.69, 0.69, and 0.69 for Q1 2026, Q4 2025, and Q3 2025 respectively.